Similarly, in the experiments with CEA‐positive tumor cells as target cells, the expression levels of CD25 and CD69 on CEA‐CAR‐T cells surface under CEA‐CAR‐T cells in combination with rhIL‐12 treatment were significantly higher than CEA‐CAR‐T cell treatment. This evidence concerns the gene SPRR2A and neoplasm.